David I. Daikh , M.D., Ph.D.

-Assistant Professor in-Residence of Medicine
-Chief, Division of Rheumatology, VA Medical Center
-Director, Rheumatology Clinical Fellows Program

-Staff Physician, SF VA Medical Center

 


San Francisco VA Medical Center
Immunology Section 111R4
150 Clement Street
San Francisco, CA 94121
phone: (415) 750-2104
fax: (415)750-6920
email: daikh@itsa.ucsf.edu

Education and Training

1977-1982 University of Oregon, Robert D. Clark Honors College - B.A. (Chemistry)

1984-1991 Oregon Health Sciences University School of Medicine - M.D.

1987-1991 Oregon Health Sciences University
Vollum Institute, Portland, Oregon - Ph.D., (Biochemistry and Molecular Biology)

1991-1994 Medical Resident, University of California, San Francisco

1994-1997 Fellow in Rheumatology, UCSF

Liscensure

1993 Medical Board of California, No. 75991
1994 American Board of Internal Medicine
1996 Rheumatology Subspecialty Board

Employment

Hospital Appointments
1995-2000 Medical Staff UCSF Medical Center
1997-2001 Visiting Staff San Francisco General Hospital
1995-present Medical Staff San Francisco VA Medical Center
1997-present Courtesy Staff Alameda County Medical Center

Administrative Appointments

Co-Director, Rheumatology Fellowship Training Program
Co-Director, UCSF Lupus Research Center

Honors and Awards

1987 Alpha Omega Alpha medical honor society
1994 Jeff Weingarten Memorial Award
1997 ACR Senior Rheumatology Scholar Award
1998 WAFMR Clinical Science Award
1999 First Annual Ira Goldstein Rheumatology Teaching Award
2000 ACR/EULAR Rheumatology Scholar
2001 Arthritis Foundation Research Hero Award

Professional Societies

2003 Member, ACR Committee of Workforce and Training
2003 Chair, ACR Subcommittee on Training Competencies and Assessment
2004  Program Chair, Northern California Rheumatology Association

Invited Presentations

"Opportunities for Future Biologic Therapies for SLE"
American Academy of Dermatology 59th Annual Meeting, Washington D.C. (2001)

"Targeted Immune Suppression: New Treatments Approaches to SLE"
7th International International Congress on SLE
New York, New York, May 12, 2004

"Clinical Trial Design in Studies of Acute Gout"
Presentation to the FDA Arthritis Advisory Committee
FDA Center for Drug Evaluation and Research
Rockville, Maryland, June 3, 2004

"Regulatory T cells in Systemic Lupus Erythematosus"
T cells in Autoimmune Diseases
Annual European Congress of Rheumatology
Vienna, Austria, June 10, 2005

Selected Publications

Cunnane G, Chan, OTM, Cassafer G, Brindis S, Kaufman E, Yen BTS, Daikh DI, "Prevention of murine lupus nephritis by CTLA4Ig and cyclophosphamide," Arthritis and Rheumatism:50:1539:1548, 2004

Schumacher HR, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA and Molina, J., “Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis,” British Medical Journal, 324: 1488-92, 2002.

Daikh DI, Wofsy, D, “Cutting Edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide.” Journal of Immunology, 166,:2913-2916, 2001.

Daikh DI, Finck BF, Linsley PS, Hollenbaugh D, Wofsy D, "Cutting Edge: Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/CD40L costimulation pathways," Journal of Immunology 159:3104-3108, 1997.


   

Home | News & Events | Donate | Links | Contact | Webmaster
Copyright © 2003, The Regents of University of California. All rights reserved.